Key result
A history of bare metal stent restenosis was strongly associated with an increased risk of major adverse cardiac events after subsequent bare metal stenting of a de novo lesion.
Why the study?
Does a history of in-stent restenosis increase the risk of major adverse cardiac events in patients undergoing subsequent bare metal stenting of de novo coronary lesions?
Cohort (n=72)
Does a history of in-stent restenosis increase the risk of major adverse cardiac events in patients undergoing subsequent bare metal stenting of de novo coronary lesions?
Answers are grounded in this paper and cite their sources.
A history of bare metal stent restenosis is a strong independent predictor of major adverse cardiac events following subsequent bare metal stenting in de novo lesions.
OBJECTIVE: To investigate the risk of major adverse cardiac events (MACE) in patients with a history of bare metal stent (BMS) restenosis who undergo subsequent bare metal stenting of a geographically distinct, de novo coronary lesion. METHODS: We conducted a retrospective review of 72 BMS procedures performed in geographically distinct, de novo coronary lesions in patients with a history of previous BMS placement at least 3 months prior to the second, index stent procedure. Patients with a history of in-stent restenosis (ISR) were compared with those who had no ISR in their initial stent. RESULTS: Restenosis in the initial BMS was associated with a significant increase in MACE after placement of the index BMS (OR 20.0, 95% CI 3.86-103.58, p < 0.0001). This association was independent of traditional clinical and angiographic risk factors for restenosis. CONCLUSIONS: Restenosis of a previously placed BMS is strongly associated with MACE after placement of a subsequent BMS in a de novo coronary lesion.
No takes yet. Share an insight, caveat, or question.
Ferguson et al. (2010) conducted a cohort in Patients undergoing bare metal stenting of de novo coronary lesions with a history of previous BMS placement (n=72). History of in-stent restenosis (ISR) in initial BMS vs. No ISR in initial stent was evaluated on Major adverse cardiac events (MACE) (OR 20.0, 95% CI 3.86-103.58, p=< 0.0001). A history of bare metal stent restenosis was strongly associated with an increased risk of major adverse cardiac events after subsequent bare metal stenting of a de novo lesion.
Synapse has enriched 10 related papers. Consider them for comparative context: